Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Prepaid Assets (2021 - 2025)

Aligos Therapeutics' Prepaid Assets history spans 5 years, with the latest figure at $4.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 3.61% year-over-year to $4.9 million; the TTM value through Dec 2025 reached $4.9 million, down 3.61%, while the annual FY2025 figure was $4.9 million, 3.61% down from the prior year.
  • Prepaid Assets reached $4.9 million in Q4 2025 per ALGS's latest filing, up from $4.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.5 million in Q4 2021 to a low of $3.4 million in Q2 2023.
  • Average Prepaid Assets over 5 years is $6.1 million, with a median of $5.3 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: soared 75.83% in 2022, then crashed 59.58% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $13.5 million in 2021, then plummeted by 43.79% to $7.6 million in 2022, then plummeted by 30.16% to $5.3 million in 2023, then dropped by 4.11% to $5.1 million in 2024, then decreased by 3.61% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for ALGS's Prepaid Assets are $4.9 million (Q4 2025), $4.2 million (Q3 2025), and $4.9 million (Q2 2025).